|
|
Dr Tony Hoos
Senior Vice President, European Medical Affairs
GlaxoSmithKline
 Dr Emilio Arbe Senior Director of Clinical Research
Stiefel, a GSK company
 Dr Bryan Johnstone Senior Director, Global Health Outcomes
Eli Lilly
 Jorge Arellano Director iHE, Evidence Generation
Amgen
 Dr Eleanor Segal Vice President, Medical Safety Officer
Actelion Pharmceuticals
|
Conference:
Pre-conference workshop
30 Nov 9am - 5pm
Day 1
1 Dec 8.30am - 5:30pm
Day 2
2 Dec 8.30am - 5:30pm
Post-conference workshop
3 Dec 8.30am - 5:30pm
Location:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
The 'must attend' late phase drug development conference
|
For delegates
Late phase drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. Are you spending this money wisely? More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency.
The 2nd annual Late Phase Drug Development World Europe 2010 is the only strategic forum addressing the major challenges in conducting strategic and compliant late stage studies.
» A review of the conference by CISIV
» Get a quote
» Register online
|
"Network with peers working in late phase drug development"
|
|
Our speakers
Our eminent speaker panel includes thought leaders and practitioners in late phase trials from the industry, academia and contract services. There are speakers from a wide range of countries presenting case study updates including representatives from F.Hoffman-La Roche, Actelion Pharmaceuticals, Amgen and McNeil Janssen Scientific Affairs. In 2010 we have introduced introduce fresh strategy content as we continue to keep track of the latest developments.
» Download the brochure
» Register online
|
For sponsors
Position and profile yourself as an industry leader at the most prestigious meeting place of the year.
As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives.
» Find out how you could benefit
» Download the brochure
|
Why should you sponsor this event?
The 2nd annual Late Phase Drug Development World aims to attract the biggest gathering of pharmaceutical late phase drug development thought leaders to assemble in 2010. How are you going to make sure you stand out from the crowd? Invest in the event, your company’s future; and make sure your clients know who you are.
The event will attract Directors and Managers of Clinical trials, Clinical research, Post marketing, Surveillance, Medical Affairs, Pharmacoepidemiology, Investigator sponsored studies, Clinical Data, Management, Drug development, Pharmacovigilance, Risk Management from the pharmaceutical and biotechnology industries.
- Learn from top level speakers
- Uncover new opportunities and generate leads
- Gain access to your target market
- Integrate with the pharma marketing community
- Enhance your brand and market position
- Showcase your products and services
» Find out more
» Looking for an event taking place sooner or in a different part of the world?
|
|
|
|
As a sponsor of this event you will be able to consider the most appropriate way to present your products and services and select a sponsorship package that is best suited to your marketing objectives and your preferred communication style.
| |
Reserve a stand
For details contact
Roope Ghosh on +44 (0) 207 608 7037 |
|
|
|
|
|
|
|
|
|
